ArticleRedox biology2019

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway.

Yunjiang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.